MIDWEST BIOFLUIDS Trademark

Trademark Overview

On Monday, July 10, 2017, a trademark application was filed for MIDWEST BIOFLUIDS with the United States Patent and Trademark Office. The USPTO has given the MIDWEST BIOFLUIDS trademark a serial number of 87522277. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, December 27, 2023. The MIDWEST BIOFLUIDS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
midwest biofluids

General Information

Serial Number87522277
Word MarkMIDWEST BIOFLUIDS
Filing DateMonday, July 10, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, December 27, 2023
Registration Number5543865
Registration DateTuesday, August 21, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2018

Trademark Statements

Pseudo MarkMIDWEST BIO FLUIDS
Disclaimer with Predetermined Text"BIOFLUIDS"
Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 16, 2017
Primary Code042
First Use Anywhere DateTuesday, December 11, 2001
First Use In Commerce DateTuesday, December 11, 2001

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressGLEN ELLYN, IL 60137
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressGLEN ELLYN, IL 60137
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressGLEN ELLYN, IL 60137

Trademark Events

Event DateEvent Description
Wednesday, December 27, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, December 27, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, December 27, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 7, 2023TEAS SECTION 8 RECEIVED
Monday, August 21, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 21, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, June 6, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 5, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 1, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, April 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 30, 2018USE AMENDMENT ACCEPTED
Wednesday, April 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 4, 2018AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, April 4, 2018USE AMENDMENT FILED
Tuesday, April 3, 2018TEAS AMENDMENT OF USE RECEIVED
Tuesday, March 20, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 20, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017NON-FINAL ACTION WRITTEN
Thursday, October 5, 2017ASSIGNED TO EXAMINER
Sunday, July 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 13, 2017NEW APPLICATION ENTERED

Related Keywords

biofluids midwest development products pharmaceutical